Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome.

Abstract:

BACKGROUND/AIM:Individualized proper chemotherapy using in vitro drug sensitivity testing has been proposed as a novel therapeutic modality and shown to have better efficacy than empiric chemotherapy. However, issues around establishing a patient-derived cell culture or xenograft, the timing of the testing obtained, and the validity of testing represent major limitations to translating the use of such a technique to clinical practice. PATIENTS AND METHODS:In this study, we assessed the feasibility of an in vitro drug sensitivity technique for testing malignant pleural effusion from advanced-stage non-small cell lung cancer. RESULTS:Our technique was able to produce a turnaround time for in vitro drug sensitivity testing of less than 1 week, with a success rate of more than 90% of cases. Correlated with the individual clinical outcome, using the area under the dose response curve (AUC) could define the level of in vitro drug sensitivity as: responsive (AUC>0.25), intermediate response (0.1≤AUC≤0.25), or resistance (AUC<0.1). CONCLUSION:Data obtained from this method of drug testing were correlated with the clinical outcome. The present drug sensitivity evaluation may benefit the development of individual precision chemotherapy.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Vinayanuwattikun C,Prakhongcheep O,Tungsukruthai S,Petsri K,Thirasastr P,Leelayuwatanakul N,Chanvorachote P

doi

10.21873/anticanres.13920

subject

Has Abstract

pub_date

2019-12-01 00:00:00

pages

6981-6988

issue

12

eissn

0250-7005

issn

1791-7530

pii

39/12/6981

journal_volume

39

pub_type

杂志文章
  • A comparison of the fatty acid profiles of subcutaneous fat from women with breast cancer, benign breast disease and normal controls.

    abstract::Using gas chromatography, the fatty acid profile has been measured in subcutaneous fat obtained from women undergoing biopsy for benign and malignant breast conditions. There was a similar proportion of saturated and unsaturated fatty acids in both types or fat, suggesting that long-term differences in fatty acid cons...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Caleffi M,Ashraf J,Rowe PH,Thomas BS,Fentiman IS

    更新日期:1987-11-01 00:00:00

  • Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy.

    abstract:BACKGROUND:Radiotherapy (RT) with or without chemotherapy (CT) plays an important role as exclusive treatment in patients with head and neck squamous cell cancer (HNSCC). Unfortunately, in some cases, benefit for patients is not recorded and only treatment-related complications are registered. MATERIALS AND METHODS:Da...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pasqualetti F,Bocci G,Mey V,Menghini V,Montrone S,Cocuzza P,Ferrazza P,Seccia V,Delishaj D,Orlandini C,Fabrini MG,Danesi R

    更新日期:2015-01-01 00:00:00

  • Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.

    abstract:BACKGROUND:Basal cell carcinomas (BCCs) are the most common cutaneous tumors, accounting for approximately 70% of all malignant skin tumors. A morphometric analysis was performed to evaluate whether morphometric parameters of the nuclei of BCC tumor cells may serve as predictors for biological behavior like recurrence ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bierhoff E,Appel K,Appel T,Buettner R,Wardelmann E

    更新日期:2003-05-01 00:00:00

  • Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.

    abstract::The iron chelator deferoxamine mesylate has been shown to inhibit the growth of a variety of human malignant cell lines and the rat 13762NF mammary adenocarcinoma cell line. In vivo studies in mice have also demonstrated that an iron deficiency induced by either feeding a low iron diet or injecting the iron chelator d...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wang F,Elliott RL,Head JF

    更新日期:1999-01-01 00:00:00

  • Value of HAMA--determination in clinical practice--an overview.

    abstract::HAMAs (human anti mouse antibodies) in serum of patients may be stimulated as an immunologic reaction to the application of animal protein. They are differentiated into heterophilic (species-unspecific) and mouse-specific anti-isotypic (often IgG1) or-idiotypic antibodies as well as according to the human immunoglobul...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Hasholzner U,Stieber P,Meier W,Lamerz R

    更新日期:1997-07-01 00:00:00

  • 5,6-Dihydro-5'-azacytidine (DHAC) affects estrogen sensitivity in estrogen-refractory human breast carcinoma cell lines.

    abstract:BACKGROUND:There is little effective therapy for patients with hormone-refractory breast cancer. Hormone resistance is frequently due to the transcriptional inactivation of the estrogen receptor (ER) gene. We determined the effect of DHAC, a cytosine DNA methyltransferase (CMT) inhibitor, on the estrogen sensitivity in...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Izbicka E,Davidson KK,Lawrence RA,MacDonald JR,Von Hoff DD

    更新日期:1999-03-01 00:00:00

  • A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer.

    abstract:AIM:Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a promising target for cancer therapy. We have already started a phase I study of CRM197, a specific HB-EGF inhibitor, for advanced ovarian cancer. In this study, we evaluated possible clinical adaptations of CRM197 in combination with conventio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tsujioka H,Fukami T,Yotsumoto F,Ueda T,Hikita S,Takahashi Y,Kondo H,Kuroki M,Miyamoto S

    更新日期:2011-07-01 00:00:00

  • Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.

    abstract::CEA is discussed as a potential tumour marker for carcinomas of the urothelium. However, investigations by means of polyclonal antibodies have shown various cross reactions which are not to be expected with monoclonal antibodies (MAb). Immunohistochemistry was done with the MAb anti-CEA BW 431/26 (Behring), N 1522 (Da...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Feil G,Wechsel HW,Nelde HJ,Bichler KH

    更新日期:1999-07-01 00:00:00

  • Proteomic analysis of prostate cancer metastasis-derived prostasomes.

    abstract:BACKGROUND:The secretory epithelial cells of the prostate gland use sophisticated vehicles in the form of prostasomes to relay important information to sperm cells in semen. This prostasome-forming and secretory ability of the epithelial cells is also preserved in poorly differentiated prostate cancer cells. The aim of...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ronquist KG,Ronquist G,Larsson A,Carlsson L

    更新日期:2010-02-01 00:00:00

  • Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency.

    abstract:AIM:To evaluate the frequency of loss of mediator of DNA damage checkpoint protein 1 (MDC1) protein expression in endometrial cancer (EC) and to determine whether loss of MDC1 is associated with certain clinicopathological parameters. MATERIALS AND METHODS:MDC1 expression was examined in 426 samples of EC. The nuclear...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13870

    authors: Merentitis D,Nguyen BD,Samartzis EP,Noske A,Brandt S,Dedes KJ

    更新日期:2019-12-01 00:00:00

  • Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.

    abstract::The effects of silybinin, an antioxidant, on the pharmacokinetics of tamoxifen and its metabolite, 4-hydroxytamoxifen, were investigated in rats. A single dose of tamoxifen was administered intravenously (2 mg/kg) and orally (10 mg/kg) without or with silybinin (0.5, 2.5 and 10 mg/kg) to rats. Silybinin significantly ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kim CS,Choi SJ,Park CY,Li C,Choi JS

    更新日期:2010-01-01 00:00:00

  • ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer.

    abstract:BACKGROUND:P-glycoprotein (Pgp), encoded by the ATP-binding cassette B1 (ABCB1) gene, is an efflux transporter located on the luminal side of intestinal epithelial cells, which protects the gut from endogenous and exogenous toxins. The association of two ABCB1 polymorphisms with the occurrence of colon cancer and long-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: De Iudicibus S,De Pellegrin A,Stocco G,Bartoli F,Bussani R,Decorti G

    更新日期:2008-11-01 00:00:00

  • Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies.

    abstract::The present study was performed to investigate the prognostic impact of tumor resection on survival in children and adolescents with malignant gliomas. From the HIT-GBM data base of the Gesellschaft für Paediatrische Onkologie und Haematologie (GPOH), 85 pediatric patients with malignant non-pontine gliomas were analy...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kramm CM,Wagner S,Van Gool S,Schmid H,Sträter R,Gnekow A,Rutkowski S,Wolff JE

    更新日期:2006-09-01 00:00:00

  • Dose-dependent Changes After Proton and Photon Irradiation in a Zebrafish Model.

    abstract:BACKGROUND/AIM:The importance of hadron therapy in the cancer management is growing. We aimed to refine the biological effect detection using a vertebrate model. MATERIALS AND METHODS:Embryos at 24 and 72 h postfertilization were irradiated at the entrance plateau and the mid spread-out Bragg peak of a 150 MeV proton ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14633

    authors: Brunner S,TŐkÉs T,SzabÓ ER,Polanek R,SzabÓ IZ,Reisz Z,GubÁn BK,SzijÁrtÓ AL,Brand M,Hans S,Karsch L,Lessmann E,Pawelke J,SchÜrer M,Beyreuther E,HideghÉty K

    更新日期:2020-11-01 00:00:00

  • Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.

    abstract:BACKGROUND:To clarify the pathogenicity of multiple human papilloma virus (HPV) infection, we applied SSCP (single-strand DNA conformation polymorphism) analysis for cervical neoplastic lesions. MATERIALS AND METHODS:Two hundred and sixty-six cervical swab specimens from normal cervix (n=64), cervical dysplasia (n=95)...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nakagawa H,Sugano K,Fujii T,Kubushiro K,Tsukazaki K,Nozawa S

    更新日期:2002-05-01 00:00:00

  • Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.

    abstract:BACKGROUND:Lung cancer tissues are often infiltrated by B lymphocytes, but it is not clear whether these infiltrations represent tumor-specific immune response or a nonspecific reaction. MATERIALS AND METHODS:The serological analysis of recombinant cDNA expression libraries (SEREX) were previously modified using a sev...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yasuda M,Mizukami M,Hanagiri T,Shigematsu Y,Fukuyama T,Nagata Y,So T,Ichiki Y,Sugaya M,Takenoyama M,Sugio K,Yasumoto K

    更新日期:2006-09-01 00:00:00

  • Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.

    abstract::Anaplastic lymphoma kinase (ALK) rearrangements were first implicated as driving mutations in non-small cell lung cancer in 2007. Since then, a number of novel, small-molecule inhibitors directed against the ALK receptor have demonstrated superiority over standard chemotherapies in the treatment of ALK rearrangement-p...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.12815

    authors: Millett RL,Elkon JM,Tabbara IA

    更新日期:2018-09-01 00:00:00

  • Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.

    abstract:BACKGROUND/AIM:Multidrug resistance (MDR) is often associated with overexpression of P-glycoprotein (ABCB1) in cancer cells. Apatinib is a novel Vascular endothelial growth factor receptor-TKI (VEGFR-TKI) which inhibits the function of ABCB1 in certain cancers. This study aimed to investigate the effect of apatinib on ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13739

    authors: Zhang Q,Song Y,Cheng X,Xu Z,Matthew OA,Wang J,Sun Z,Zhang X

    更新日期:2019-10-01 00:00:00

  • Inhibition of cellular chemotactic invasion by a vinca alkaloid, conophylline.

    abstract::K-ras-NIH3T3 cells were more invasive than NIH3T3 cells in a chemotactic invasion assay. Conophylline, a new vinca alkaloid isolated as a ras function inhibitor, inhibited the invasion of K-ras-NIH3T3 cells, while it showed no effect on NIH3T3 cells. Conophylline did not increase expression of fibronectin but induced ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Amino N,Ohse T,Koyano T,Umezawa K

    更新日期:1996-01-01 00:00:00

  • Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.

    abstract:AIM:Neoadjuvant epirubicin/docetaxel (ET) combination chemotherapy was administered to breast cancer patients in order to investigate their clinical and pathological response. Moreover, the breast-conserving surgery (BCS) rate, disease-free (DFS) and overall survival (OS), safety profile and the correlation of biologic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishimura R,Rai Y,Matsuo F,Anan K,Hara S,Imamura S,Itoyanagi N,Kato M,Okido M,Kudaka M,Ishikawa E,Kamada Y,Watanabe R,Shirouzu M,Mitsuyama S,Takamatsu Y,Tamura K

    更新日期:2012-08-01 00:00:00

  • Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.

    abstract::The pattern of cytoplasmic membrane gangliosides and two cellular features which have been reported to be related to the expression of different membrane gangliosides, namely adhesion to solid substrates and susceptibility to the lytic activity of immune effector cells, have been investigated in drug sensitive A2780 h...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mazzoni A,Trave F,Fabbri M,Leto G,Ghidoni R

    更新日期:1991-11-01 00:00:00

  • Radiotherapy in the treatment of stage III-IV hypopharyngeal carcinoma.

    abstract:BACKGROUND:The aim of this study was to evaluate the role of radiation therapy alone, employing standard fractionation, in stage III-IV hypopharyngeal carcinoma. MATERIALS AND METHODS:Fourteen (38.9%) stage III and 22 (61.1%) stage IV patients with hypopharyngeal carcinoma were submitted, with curative intent, to excl...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Tombolini V,Santarelli M,Raffetto N,Donato V,Valeriani M,Ferretti A,Enrici RM

    更新日期:2004-01-01 00:00:00

  • Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling.

    abstract:BACKGROUND:Breast cancer cells frequently metastasize to the skeleton and produce and secrete proteinases, such as matrix metalloproteinase-13 (MMP-13), which promote destruction of the bone matrix. However, the mechanism of MMP-13 expression induced in areas of bone metastasis is unknown. Here, the interaction between...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ibaragi S,Shimo T,Hassan NM,Isowa S,Kurio N,Mandai H,Kodama S,Sasaki A

    更新日期:2011-04-01 00:00:00

  • CA 125 measurement in the follow-up of breast cancer patients.

    abstract::During follow-up examinations for breast cancer the serum tumor marker CA 125 was measured routinely in the Universitätsfrauenklinik Erlangen. We found elevated CA 125 levels in 18 of 510 clinical asymptomatic patients. These patients were followed closely. A second malignant neoplasm was found in six of these patient...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Böhmer C,Jäger W,Lang N

    更新日期:1997-07-01 00:00:00

  • Ultrastructural studies on the lung colonization by nonmetastatic rat tumor cells.

    abstract::The events during the settlement of BSp73AS (AS) tumor cells in the syngeneic rat lung are described. Although AS cells show highly invasive behavior in vitro, subcutaneous primary tumors grow solidly without detectable metastatic spreading. However, AS cells when applied to the syngeneic rats via the tail vein give r...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Knierim M,Paku S,Paweletz N,Spiess E

    更新日期:1986-07-01 00:00:00

  • Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.

    abstract:BACKGROUND AND AIM:The Seventh American Joint Committee on Cancer (AJCC)/TNM classification defined that the classification for adenocarcinoma of the esophagogastric junction (AEG) was included in the esophageal category. However, there still remain various classifications in AEG such as the Seventh AJCC/TNM of the eso...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawaguchi T,Komatsu S,Ichikawa D,Kubota T,Okamoto K,Shiozaki A,Fujiwara H,Konishi H,Morimura R,Murayama Y,Kuriu Y,Ikoma H,Nakanishi M,Sakakura C,Otsuji E

    更新日期:2013-08-01 00:00:00

  • Alpha-fetoprotein-positive carcinoma of the pancreas: a case report.

    abstract::We report on the case of a 19-year-old male with an alpha-fetoprotein (AFP)-producing acinar cell carcinoma of the pancreas. Tumour markers other than AFP were normal. Because of inoperability, a combined radiochemotherapy was initiated with a hyperfractionated dose of 44.8 Gy. Initially, the tumour showed a good resp...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mueller SB,Micke O,Herbst H,Schaefer U,Willich N

    更新日期:2005-05-01 00:00:00

  • Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients.

    abstract:BACKGROUND/AIM:Reportedly, hypertension tends to be associated with response to bevacizumab therapy, because bevacizumab suppresses vascular nitric oxide production. In this study we examined the predictive value of nitric oxide in bevacizumab-treated non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS:F...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11676

    authors: Muto S,Takagi H,Owada Y,Inoue T,Watanabe Y,Yamaura T,Fukuhara M,Okabe N,Matsumura Y,Hasegawa T,Osugi J,Hoshino M,Higuchi M,Shio Y,Suzuki H

    更新日期:2017-06-01 00:00:00

  • Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.

    abstract::Human leukocyte antigen (HLA)-E and HLA-F are classified as non-classical HLA class Ib antigens. Ectopic HLA-E and HLA-F expression was recently detected in cancer cells; however, the clinical implication of their expression remains unknown. A total of 209 patients with gastric cancer were enrolled in this study. Immu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ishigami S,Arigami T,Okumura H,Uchikado Y,Kita Y,Kurahara H,Maemura K,Kijima Y,Ishihara Y,Sasaki K,Uenosono Y,Natsugoe S

    更新日期:2015-04-01 00:00:00

  • Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy.

    abstract::Xenograft hyperacute rejection in humans occurs as a secondary response to a cellular glycosylation incompatibility with most non-human mammalian species. A key component of hyperacute rejection, alpha(1,3)galactosyl (agal) epitopes present on the surface of most non-human mammal cells, is bound by host anti-agal IgG ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Link CJ Jr,Seregina T,Atchison R,Hall A,Muldoon R,Levy JP

    更新日期:1998-07-01 00:00:00